Azelastine and Ranolazine drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Azelastine (azelastine hydrochloride) and Ranolazine (ranolazine). Common drug interactions include infusion site extravasation among females and death among males.

The phase IV clinical study analyzes what interactions people have when they take Azelastine and Ranolazine. It is created by eHealthMe based on reports of 27 people who take the same drugs from the FDA, and is updated regularly.

What is Azelastine?

Azelastine has active ingredients of azelastine hydrochloride. It is often used in allergies. eHealthMe is studying from 17,400 Azelastine users. Check the latest studies of Azelastine.

What is Ranolazine?

Ranolazine has active ingredients of ranolazine. eHealthMe is studying from 9,939 Ranolazine users. Check the latest studies of Ranolazine.

On Aug, 09, 2026

27 people who take Azelastine and Ranolazine together, and have interactions are studied.

Azelastine and Ranolazine drug interactions.

What are the common drug interactions of Azelastine and Ranolazine, by gender? *:

female:

Infusion site extravasation (flow of (blood or lymph) from infusion site)
Metabolic disorder (an abnormal function and pattern of body fat. insulin resistance refers to the diminished ability of cells to respond to the action of insulin in promoting the transport of the sugar glucose, from blood into muscles and other tissues)
Respiratory distress (difficulty in breathing)
Cardiac disorder
Drug hypersensitivity
Gastric disorder (disease of stomach)
Gastric ulcer haemorrhage (bleeding ulcer of stomach)
Visual impairment
Allergic cough
Aphasia (damage to the parts of the brain that control language)

male:

Death
Frequent bowel movements
Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
Constipation
Hypoacusis (loss of hearing)
Insomnia (sleeplessness)
Terminal state (the transitional states between life and biological death)
Vertigo
Arthralgia (joint pain)
Guttate psoriasis (a type of psoriasis that looks like small drops on the skin)

What are the common drug interactions of Azelastine and Ranolazine, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

Cardiac disorder
Gastric disorder (disease of stomach)
Gastric ulcer haemorrhage (bleeding ulcer of stomach)
Drug hypersensitivity
Cardiac arrest
Completed suicide (act of taking one's own life)
Mental status changes (general changes in brain function, such as confusion, amnesia (memory loss), loss of alertness, loss of orientation)
Respiratory arrest (cessation of normal respiration due to failure of the lungs to function effectively)

60+:

Frequent bowel movements
Death
Blood pressure decreased
Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
Constipation
Cough
Diarrhoea
Drug hypersensitivity
Dyspnoea (difficult or laboured respiration)

What are the existing conditions these people have? *

Immunodeficiency Common Variable: 4 people, 14.81%
Stable Angina (a constant chest pain): 2 people, 7.41%
Pain: 2 people, 7.41%
Myeloid Leukaemia (a type of cancer in which the bone marrow makes abnormal myeloblasts): 2 people, 7.41%
Idiopathic Pulmonary Fibrosis (chronic lung disease): 2 people, 7.41%
High Blood Cholesterol: 2 people, 7.41%
Constipation: 2 people, 7.41%
Chest Pain: 2 people, 7.41%

* Approximation only. Some reports may have incomplete information.

Do you take Azelastine and Ranolazine?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously